These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257 [TBL] [Abstract][Full Text] [Related]
26. [Current therapeutic options in Mycosis fungoides and Sézary syndrome]. Albrecht JD; Nicolay JP Hautarzt; 2022 Jan; 73(1):75-85. PubMed ID: 34988613 [TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
28. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome. Jothishankar B; Almazan T; Kim Y; Liauw S; Smith S; Kline J; Abdulla F Br J Haematol; 2019 Jul; 186(2):377-379. PubMed ID: 30937886 [No Abstract] [Full Text] [Related]
30. [T cell subsets and nuclear contour index of skin-infiltrating T cells in mycosis fungoides and Sézary syndrome]. Iwahara K Nihon Hifuka Gakkai Zasshi; 1984 Nov; 94(13):1499-507. PubMed ID: 6335535 [No Abstract] [Full Text] [Related]
31. Therapy of cutaneous lymphoma--current practice and future developments. Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705 [TBL] [Abstract][Full Text] [Related]
32. Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach. Horwitz SM; Olsen EA; Duvic M; Porcu P; Kim YH J Natl Compr Canc Netw; 2008 Apr; 6(4):436-42. PubMed ID: 18433609 [TBL] [Abstract][Full Text] [Related]
33. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis. Vural S; Akay BN; Botsalı A; Atilla E; Parlak N; Okçu Heper A; Şanlı H Turk J Haematol; 2018 Mar; 35(1):35-41. PubMed ID: 28533196 [TBL] [Abstract][Full Text] [Related]
35. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Tsai EY; Taur A; Espinosa L; Quon A; Johnson D; Dick S; Chow S; Advani R; Warnke R; Kohler S; Hoppe RT; Kim YH Arch Dermatol; 2006 May; 142(5):577-84. PubMed ID: 16702495 [TBL] [Abstract][Full Text] [Related]
36. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. Sentis HJ; Willemze R; Scheffer E J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972 [TBL] [Abstract][Full Text] [Related]